Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03695276 · ClinicalTrials.gov registry record · NA

Pulmonary Specialist-Health Coach Consult Model Study

A NA study, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
328
Enrollment target

NCT03695276: Completed NA study, sponsored by University of California, San Francisco.

NCT03695276 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 328 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03695276, a NA study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
328 participants
Enrollment target

Study Summary

The Pulmonary Specialist-Health Coach Consultation (PuSHCon) study examines the implementation of health coach-assisted consultations to improve access to specialist care and implementation of specialist recommendations for patients with COPD, asthma, and asthma COPD overlap syndrome (ACOS) for low-income and vulnerable patients seen at public health clinics. Three hundred sixty (360) patients from ten clinics will be enrolled in the study and randomized at the individual level to receive health coaching or usual care; 180 patients will receive usual care and 180 patients will receive the PuSHCon model.

Primary Outcome

Numerator: Number of guideline-based recommendations implemented by the patient; Denominator: Number of minimal recommendations based on GOLD/GINA guidelines

Interventions

  • BEHAVIORAL Usual care
  • BEHAVIORAL PushCon Model

Trial Details

FieldValue
Enrollment Target 328 participants
Start Date 2020-10-20
Est. Completion 2025-01-31
Phase NA

What the finished NCT03695276 record still lists

NCT03695276 is an interventional study that assigns participants to a tested intervention. The registered 328 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).

The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.

NCT03695276 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03695276 about?

NCT03695276 is a clinical study titled "Pulmonary Specialist-Health Coach Consult Model Study". The Pulmonary Specialist-Health Coach Consultation (PuSHCon) study examines the implementation of health coach-assisted consultations to improve access to specialist care and implementation of specialist recommendations for patients with COPD, asthma, and asthma COPD overlap syndrome (ACOS) for low-...

What is the current status of trial NCT03695276?

This trial is currently completed. It is a NA study. The enrollment target is 328 participants. The study started on 2020-10-20. Estimated completion is 2025-01-31.

What interventions are being tested in trial NCT03695276?

The interventions under investigation include: Usual care (BEHAVIORAL), PushCon Model (BEHAVIORAL).

Who is sponsoring clinical trial NCT03695276?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03695276's enrollment target sits among peer trials

328 308th of 2000 higher than 1,692 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05156983 · 328 participants · Phase 3

    A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

  • NCT05380401 · 328 participants · NA

    Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

  • NCT05548413 · 328 participants · NA

    Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies

  • NCT06393725 · 328 participants · NA

    Synchronous vs Asynchronous Remotely Delivered Lifestyle Interventions

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03695276, the US trial registry maintained by the National Library of Medicine. NCT03695276 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.